Management at Varian Medical Systems Oncology Systems business unit has been restructured to consolidate global operations and provide additional management resources for developing early-stage emerging businesses, according to company CEO and president
Management at Varian Medical Systems Oncology Systems business unit has been restructured to consolidate global operations and provide additional management resources for developing early-stage emerging businesses, according to company CEO and president Richard M. Levy. Tim Guertin is the company's new executive vice president. Guertin will continue as president of Varian's Oncology Systems business in addition to assisting Levy with corporate issues. Several other new appointments were made within Oncology Systems.
John Ford, corporate vice president, has been named senior vice president for Oncology Systems, responsible for facilitating major customer, government, and partnering initiatives. Jeff Marcus, vice president of Oncology Systems, will assume responsibility for the worldwide sales organization. Paul Rowland, vice president of North American sales, Oncology Systems, will head the sales organization in the U.S. and Canada. He will report to Marcus. The medical manufacturing operations for Oncology Systems will be combined under Keith Krugman, corporate vice president and vice president, Oncology Systems, who will have continuing responsibility for worldwide customer support functions. Elaine McKinley has been appointed vice president, Oncology Systems customer support, reporting to Krugman. Product engineering and marketing have been combined under the direction of Kolleen Kennedy, vice president, Oncology Systems. Ueli Graf, vice president, worldwide engineering, Oncology Systems, will report to Kennedy.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.